Epstein-Barr Virus Antibody to Viral Capsid Antigen, IgG and IgA
0051627
Ordering Recommendation
Do not use for diagnosis of Epstein-Barr virus infectious mononucleosis. May aid in the detection and prognosis of nasopharyngeal carcinoma.
Mnemonic
EBV PAN 3
Methodology
Enzyme-Linked Immunosorbent Assay/Semi-Quantitative Chemiluminescent Immunoassay
Performed
Tue
Reported
1-8 days  
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
Specimen Required
Patient Preparation
  
Collect
Serum separator tube.  
Specimen Preparation
Separate serum from cells ASAP or within 2 hours of collection. Transfer 2 mL serum to an ARUP Standard Transport Tube. (Min: 0.5 mL) Parallel testing is preferred and convalescent specimens must be received within 30 days from receipt of the acute specimens. Mark specimens plainly as "acute" or "convalescent."  
Storage/Transport Temperature
Refrigerated.  
Unacceptable Conditions
Plasma. Urine. Contaminated, grossly hemolyzed, or heat-inactivated specimens.  
Remarks
  
Stability
After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles)  
Reference Interval
 
 
Test Number Components Reference Interval
0050235Epstein-​Barr Virus Antibody to Viral Capsid Antigen, IgG Effective February 19, 2013

17.9 U/mL or less: Not Detected
18.0-​21.9 U/mL:  Indeterminate.  Repeat testing in 10-​14 days may be helpful.
22.0 U/mL or greater: Detected
0051626Epstein-​Barr Virus Antibody to Viral Capsid Antigen, IgA Effective February 19, 2013

0.79 U/mL or less:  Not Detected
0.80 -​ 1.20 U/mL: Indeterminate.  Repeat testing in 10-​14 days may be helpful.
1.21 U/mL or greater:  Detected
Interpretive Data


See Compliance Statement D: www.aruplab.com/CS
Statement D: This test was developed and its performance characteristics determined by ARUP Laboratories. The U.S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.
 
Note
 
CPT Code(s)
86665 x2
Components
Component Test Code*Component Chart NameLOINC
0050235EBV Antibody to Viral Capsid Antigen IgG5157-3
0051626EBV Antibody To Viral Capsid Antigen IgA 
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • EBV and VCA Ab
  • EBV Antibodies
  • EBV VCA-Ab
  • Infectious Mononucleosis